PERCE-MUCONCT07885410
PERCE-MUCO: Perceptions and Expectations of People With Cystic Fibrosis Regarding a Change in Treatment
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
- Minor Study sites: 11 to 12
- Secondary endpoints revised (6)
- Study First Submitted
- Minor: routine updates
Endpoints
Primary
Intention to switch from ETI to VTD
Timeframe: Day 1, (single assessment).
Secondary (6)
Factors influencing willingness to switch
Correlation between quality of life and intention to switch
Correlation between treatment adherence and intention to switch
Relationship between reported ETI tolerability and intention to switch
Need for support during a potential treatment transition
Show 1 moreShow less
Patient perceptions and barriers identified in semi-structured interviews
Arms and interventions
Adults with cystic fibrosis treated with ETI or with medically discontinued ETI
Adults with cystic fibrosis who have received ETI for at least 3 months or whose ETI treatment was discontinued for medical reasons. The study observes treatment preferences and associated characteristics; it does not assign or require a change in treatment.
Sites
12 sites in 1 country